Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds

CPL Cosentinoa, L Ricciardielloa - 2024 - karger.com
Background: Colorectal cancer is known as one of the “big killers” in oncology given its
burden in terms on morbidity and mortality. Since the second half of the last century, similarly …

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung Cancer

D Dora, P Kiraly, C Somodi, B Ligeti, E Dulka, G Galffy… - 2024 - researchsquare.com
Background: Advanced-stage non-small cell lung cancer (NSCLC), presents significant
treatment challenges, with immune checkpoint inhibitor (ICI) combinations being the primary …

HCC: Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation

Y Saleh, TA Hejleh, M Abdelrahim, A Shamseddine… - 2024 - preprints.org
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths.
Classically, liver transplantation (LT) can be curable for HCC tumors within the Milan criteria …

[PDF][PDF] Alterations of Circulating and Tissue-Associated Microbiome Profiles in the Case of Gastric and Colorectal Cancers

D Nikitina - 2024 - lsmu.lt
Gastrointestinal (GI) tract cancers are considered one of the main public health problems
with medical and economic burdens because of their high prevalence and mortality rate …

[PDF][PDF] Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment. Microorganisms 2023, 11, 1898

C Thoda, M Touraki - 2023 - researchgate.net
Colorectal cancer (CRC) is a multifactorial disease with increased morbidity and mortality
rates globally. Despite advanced chemotherapeutic approaches for the treatment of CRC …

Fecal microbiota, serum biomarkers, diet and lifestyle: colorectal cancer risk and prognosis

F Bellerba - 2023 - air.unimi.it
Colorectal cancer (CRC) is the result of a complex interaction between non-modifiable and
modifiable risk factors. The modifiable factors include obesity, diet, lifestyle choices …

The Immune Interactions of Gut Glycans and Microbiota in Health and Disease

FY Avci, M Demirturk, MS Cinar - Authorea Preprints, 2023 - authorea.com
The human digestive system harbors a vast diversity of commensal bacteria and maintains a
symbiotic relationship with them. However, imbalances in the gut microbiota, known as …

Microbiome‐driven anticancer therapy: A step forward from natural products

Y Guan, D Wu, H Wang, NN Liu - mLife - Wiley Online Library
Human microbiomes, considered as a new emerging and enabling cancer hallmark, are
increasingly recognized as critical effectors in cancer development and progression …

Das intestinale Mikrobiom bei gastroenterologischen Krankheitsbildern

W Reindl - Gastroenterologie up2date, 2023 - thieme-connect.com
Zwischen dem intestinalen Mikrobiom und dem Individuum besteht eine intensive,
lebenslange Wechselwirkung. Das Mikrobiom reguliert physiologische Prozesse und ist …

The causal relationship between gut microbiota and two neoplasms, malignant and benign neoplasms of bone and articular cartilage: a two-sample mendelian …

J Lv, X Qin, J Wang, J Li, J Bai, Y Lan - 2024 - researchsquare.com
Background Previous research has demonstrated a close connection between the
development of bone neoplasms and variations in the abundance of specific gut microbiota …